Daniel Gesua Sive Salvadori - Dec 13, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EXECUTIVE VICE PRESIDENT
Signature
/s/ Daniel Gesua Sive Salvadori by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Dec 13, 2021
Transactions value $
-$5,597,991
Form type
4
Date filed
12/15/2021, 05:34 PM
Next filing
Dec 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Sale -$472K -3.5K -3.26% $135.00 104K Dec 13, 2021 Direct
transaction ABT Common shares without par value Options Exercise $913K +23.8K +22.87% $38.40 128K Dec 13, 2021 Direct
transaction ABT Common shares without par value Options Exercise $1.39M +31.2K +24.45% $44.40 159K Dec 13, 2021 Direct
transaction ABT Common shares without par value Sale -$7.43M -55K -34.61% $135.00 104K Dec 13, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -23.8K -33.33% $0.00 47.5K Dec 13, 2021 Common Shares 23.8K $38.40 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -31.2K -33.93% $0.00 60.8K Dec 13, 2021 Common Shares 31.2K $44.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).